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Authors Reply:— In a recent meta-analysis, we found
that all types of distal lesions are predictive of proximal
neoplasia (PN) and that on average 60 % of PN are isolated,
that is, not accompanied by distal lesions.1 A commentary
by Dr. Filik concluded that if all types of distal lesions are
predictive of PN, colonoscopy should be performed instead
of flexible sigmoidoscopy (FS). We thank Dr. Filik for his
comment. In this reply we highlight why FS should not be
abandoned in favor of colonoscopy.
Deciding which colon inspection method is most suitable
for screening depends on many parameters, including
discomfort, complication rates, logistics, and costs.2 FS is
performed without sedation, leading to more pain than
colonoscopy. Colonoscopy has a complication rate that,
although low, is 10 times higher than that of FS. Colonoscopy
is further accompanied by a loss of three working days for
preparing for, undergoing, and recovering from the procedure,
compared to half a day in FS.
Colonoscopy has the theoretical advantage over FS that it
allows inspection of the proximal colon. Recent population-
based studies have reported that, compared to no screening,
colonoscopy led to significant reductions of cancer incidence
in the distal colon and associated mortality, but its efficacy in
the proximal colon was similar to that of FS.3 It remains
unclear whether these studies failed to show a protective
effect of colonoscopy against proximal colon cancer inci-
dence because of poor design or practical limitations (e.g., by
including cases in which colonoscopy was performed by
non-gastroenterologists), inherent visualization problems of
colonoscopy (e.g., miss of flat and pale proximal adenomas),
or inherent properties of the proximal colon (e.g., the
aggressive nature of proximal tumors). Randomized controlled
trials of screening colonoscopy are underway, but their results
will not be available before 2021.
In an effort to improve the predictive value of FS, Imperiale
et al.4 introduced a clinical index including distal findings,
gender, and age. The index was applied to a cohort of
asymptomatic individuals 50 years or older undergoing
screening colonoscopy for the first time and detected 92 %
of individuals with advanced proximal neoplasia. Using the
index could reduce the number of screening colonoscopies by
40 % as compared to sending everyone to colonoscopy. In our
meta-analysis, health characteristics were an important mod-
erator of the association between distal and proximal lesions,
with proximal advanced neoplasia being better predicted in
asymptomatic populations, young populations, and popula-
tions with a low prevalence for proximal advanced neoplasia.
Combining the FS outcome with demographics, health
characteristics, genetic predisposition, and environmental risks
can improve the prediction of PN and strengthen the role of FS
as a screening modality. Technological advances in imaging
and visualization as well as emerging techniques such as virtual
colonoscopy will also contribute to future lesion detection.
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